These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31277936)

  • 1. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
    Chu Y; Luo Y; Ji S; Jiang M; Zhou B
    J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
    Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
    Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
    Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
    Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
    Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
    J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Population pharmacokinetics of vancomycin from severe in patients with lower respiratory tract infection].
    Yang W; He B; Deng CH
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):205-209. PubMed ID: 28297816
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
    Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
    Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.
    Chu Y; Luo Y; Qu L; Zhao C; Jiang M
    Pharm Biol; 2016 Dec; 54(12):2802-2806. PubMed ID: 27251880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of vancomycin in Chinese infants
.
    Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis.
    Xu J; Zhu Y; Niu P; Liu Y; Li D; Jiang L; Shi D
    Pediatr Neonatol; 2022 Jan; 63(1):57-65. PubMed ID: 34544677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
    Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.
    Zhang H; Wang Y; Gao P; Hu J; Chen Y; Zhang L; Shen X; Xu H; Xu Q
    J Clin Pharmacol; 2016 Jun; 56(6):740-8. PubMed ID: 26440302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
    Yamamoto M; Kuzuya T; Baba H; Yamada K; Nabeshima T
    J Clin Pharm Ther; 2009 Aug; 34(4):473-83. PubMed ID: 19583681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections.
    Zhou Y; Gao F; Chen C; Ma L; Yang T; Liu X; Liu Y; Wang X; Zhao X; Que C; Li S; Lv J; Cui Y; Yang L
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):361-370. PubMed ID: 30506225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic and pharmacodynamic modeling of norvancomycin.
    Zhang J; Zhang Y; Shi Y; Rui J; Yu J; Cao G; Wu J
    Eur J Clin Microbiol Infect Dis; 2008 Apr; 27(4):275-84. PubMed ID: 18188617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vancomycin in adult cancer patients.
    Al-Kofide H; Zaghloul I; Al-Naim L
    J Oncol Pharm Pract; 2010 Dec; 16(4):245-50. PubMed ID: 20015925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance.
    He CY; Ye PP; Liu B; Song L; van den Anker J; Zhao W
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0089721. PubMed ID: 34339268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients.
    Zhou Y; Long E; Shi T; Wang Z; Zhao J; Liu H; Lin Y; Jiang M; Lao H; Ge W; Cui Y
    J Glob Antimicrob Resist; 2022 Sep; 30():163-172. PubMed ID: 35640870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.